Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

A once-a-day pill health experts are calling 'life-changing' will be offered to hundreds of people living with cystic ...

Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for ALYFTREK ...

Alfie Coe, 13, from Terrington St Clement, will be running 3km daily during his school summer holidays to raise money for the ...

Then the sunrise was amazing and then you gotta get through the heat and kind of battling through rest of that distance for ...

Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) therapy has been recommended by the National Institute for ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense Oligonucleotide (ASO) ...

Over the last 7 days, the United States market has remained flat, yet it has experienced an 11% increase over the past year with earnings projected to grow by 15% annually. In this environment, ...

John Thomas Tilton, after extended illness, gained his heavenly wings at his Wilson home, surrounded by loved ones. John is survived by his wife of 56 years, Brenda Harrell Tilton; and grandson, ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...